We are live on
!
Find out more
EPRX
Eupraxia Pharmaceuticals
EPRX
EPRX
54 hedge funds and large institutions have $156M invested in Eupraxia Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
50% more capital invested
Capital invested by funds: $104M → $156M (+$52.3M)
9.08% more ownership
Funds ownership: 27.31% → 36.39% (+9.1%)
Holders
54
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$10.4M | |
| 2 | +$5.63M | |
| 3 | +$5.56M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$4.87M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.37M |
Top Sellers
| 1 | -$2.09M | |
| 2 | -$500K | |
| 3 | -$345K | |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
-$326K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$122K |
